For which indications is etoricoxib (a selective COX‑2 inhibitor) used?

Etoricoxib Indications

Etoricoxib is approved for symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, and acute pain conditions including primary dysmenorrhea and dental surgery pain. 1, 2, 3

Approved Indications

Chronic Inflammatory Conditions

• Osteoarthritis: 60 mg once daily 2, 4
• Rheumatoid arthritis: 90 mg once daily 2, 4
• Ankylosing spondylitis: Demonstrated efficacy in recent studies 3

Acute Pain Conditions

• Acute gouty arthritis: 120 mg once daily 5, 2, 4
  • Etoricoxib is the only COX-2 selective inhibitor specifically approved for acute gout 3
  • Provides effective pain relief comparable to traditional NSAIDs 5
• Acute postoperative pain: 120 mg single dose provides high-quality pain relief (NNT 1.9) 6
• Primary dysmenorrhea: 120 mg daily 2
• Dental surgery pain: Approved in some countries 2
• Chronic low back pain: 60 mg daily 2

Clinical Context and Positioning

When to Consider Etoricoxib

Etoricoxib should be considered as a treatment option when:

• Patients require NSAID therapy for the above conditions
• Patients are at high risk for gastrointestinal complications but low cardiovascular risk 3
• Traditional NSAIDs have caused gastrointestinal adverse effects 1

The drug reduces uncomplicated upper GI adverse events by approximately 50% compared to nonselective NSAIDs 1, 7, with investigator-reported upper GI perforations, ulcers, and bleeds cut in half 7.

Critical Contraindications and Cautions

However, etoricoxib has significant cardiovascular considerations that limit its use:

Absolute Contraindications

• Uncontrolled hypertension (European Medicines Agency contraindication) 3
• Ischemic heart disease or stroke 3
• Post-CABG surgery (first 10-14 days) 8, 9

Relative Contraindications

• Known cardiovascular disease or CV risk factors 8, 10, 11
• Patients taking low-dose aspirin (negates GI-sparing benefits) 12, 13
• Elderly patients (>65 years) require extreme caution 13, 14

In the MEDAL program, etoricoxib showed non-inferiority to diclofenac for cardiovascular thrombotic events 11, 1, but the 2008 NICE osteoarthritis guidelines specifically recommend against using etoricoxib 60 mg as a first-choice COX-2 inhibitor 15.

Dosing Principles

Use the lowest effective dose for the shortest possible duration 15, 8, 10, 9, 1:

• Chronic conditions: 60-90 mg daily
• Acute pain/gout: 120 mg daily (short-term only)

Gastroprotection Strategy

When etoricoxib is used:

• Co-prescribe a proton pump inhibitor if the patient is also taking low-dose aspirin 12, 13, 14
• Consider PPI co-therapy in high-risk patients (age >65, history of ulcer, concurrent corticosteroids) 12, 16

Common Pitfall

The major clinical pitfall is prescribing etoricoxib to patients with cardiovascular disease or uncontrolled hypertension. Always assess cardiovascular risk factors before initiating therapy 8, 10, 11. The stepped-care approach for musculoskeletal pain in CV patients should begin with acetaminophen, then nonacetylated salicylates or nonselective NSAIDs, before considering any COX-2 selective agent 8, 10.